81 related articles for article (PubMed ID: 8472118)
1. Sensitivity of human squamous cell carcinoma of the larynx to fractionated radiotherapy.
Rezvani M; Fowler JF; Hopewell JW; Alcock CJ
Br J Radiol; 1993 Mar; 66(783):245-55. PubMed ID: 8472118
[TBL] [Abstract][Full Text] [Related]
2. Dose, time, and fraction size issues for late effects in head and neck cancers.
Taylor JM; Mendenhall WM; Lavey RS
Int J Radiat Oncol Biol Phys; 1992; 22(1):3-11. PubMed ID: 1727126
[TBL] [Abstract][Full Text] [Related]
3. The role of epidermal growth factor receptor and E-cadherin for the outcome of reduction in the overall treatment time of radiotherapy of supraglottic larynx squamous cell carcinoma.
Eriksen JG; Steiniche T; Overgaard J;
Acta Oncol; 2005; 44(1):50-8. PubMed ID: 15848906
[TBL] [Abstract][Full Text] [Related]
4. [Clinical characteristics and multivariate analysis of prognostic factors in recurrent laryngeal carcinoma].
Chen YF; Chen FJ; Yang AK; Zeng ZY; Song M; Li QL
Ai Zheng; 2004 May; 23(5):584-8. PubMed ID: 15142460
[TBL] [Abstract][Full Text] [Related]
5. Accelerated versus conventional fractionation in the postoperative irradiation of locally advanced head and neck cancer: influence of tumour proliferation.
Awwad HK; Khafagy Y; Barsoum M; Ezzat S; el-Attar I; Farag H; Akoush H; Meabid H; Zaghloul MS
Radiother Oncol; 1992 Dec; 25(4):261-6. PubMed ID: 1480771
[TBL] [Abstract][Full Text] [Related]
6. Tumour volume: implications in T2/T3 glottic/supraglottic squamous cell carcinoma.
Lo SM; Venkatesan V; Matthews TW; Rogers J
J Otolaryngol; 1998 Oct; 27(5):247-51. PubMed ID: 9800621
[TBL] [Abstract][Full Text] [Related]
7. [Results of postoperative cervical node irradiation in carcinoma of the pharyngo-larynx. A study of the cooperative group of radiotherapists].
Hoffstetter S; Malissard L; N'Guyen TD; Panis X; Jung GM; Bachaud JM; Prevost B; Quint R; Chaplain G; Eschwège F; Rambert P; Fleury-Touzeau F
Bull Cancer Radiother; 1996; 83(2):86-9. PubMed ID: 8688224
[TBL] [Abstract][Full Text] [Related]
8. Hyperfractionated radiation in the treatment of squamous cell carcinomas of the head and neck: a comparison of two fractionation schedules.
Garden AS; Morrison WH; Ang KK; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):493-502. PubMed ID: 7852111
[TBL] [Abstract][Full Text] [Related]
9. Influence of overall treatment time and radiobiological parameters on biologically effective doses in cervical cancer patients treated with radiation therapy alone.
Gasinska A; Fowler JF; Lind BK; Urbanski K
Acta Oncol; 2004; 43(7):657-66. PubMed ID: 15545186
[TBL] [Abstract][Full Text] [Related]
10. Radiation treatment of T1-T4 squamous cell carcinoma of the larynx: a retrospective analysis and long-term follow-up of 135 patients.
Bergqvist M; Brodin O; Pouzon A; Linder A; Hesselius P; Blomquist E
Anticancer Res; 2002; 22(2B):1239-42. PubMed ID: 12168932
[TBL] [Abstract][Full Text] [Related]
11. Final report of the general clinical results of the British Institute of Radiology fractionation study of 3F/wk versus 5F/wk in radiotherapy of carcinoma of the laryngo-pharynx.
Wiernik G; Bates TD; Bleehen NM; Brindle JM; Bullimore J; Fowler JF; Haybittle JL; Howard N; Laing AH; Lindup R
Br J Radiol; 1990 Mar; 63(747):169-80. PubMed ID: 2185865
[TBL] [Abstract][Full Text] [Related]
12. Role of accelerated fractionated irradiation for supraglottic carcinoma: assessment of results.
Wang CC; Nakfoor BM; Spiro IJ; Martins P
Cancer J Sci Am; 1997; 3(2):88-91. PubMed ID: 9099458
[TBL] [Abstract][Full Text] [Related]
13. Impact of cervical disease and its definitive radiotherapeutic management on survival: experience in 2013 patients with squamous cell carcinomas of the oropharynx and pharyngolarynx.
Bataini JP; Bernier J; Jaulerry C; Brunin F; Pontvert D
Laryngoscope; 1990 Jul; 100(7):716-23. PubMed ID: 2362531
[TBL] [Abstract][Full Text] [Related]
14. Seventh interim progress report of the british institute of radiology fractionation study of 3F/week versus 5F/week in radiotherapy of the laryngo-pharynx.
Wiernik G; Bates TD; Berry RJ; Brindle J; Bullimore J; Dalby JE; Flatman GE; Fowler JF; Hadden RC; Haybittle JL; Henk JM; Howard N; Ledda J; Lindup R; Phillips DL; Pointon RS; Sambrook DK; Skeggs D
Br J Radiol; 1982 Jul; 55(655):505-10. PubMed ID: 7150898
[TBL] [Abstract][Full Text] [Related]
15. Exclusive radiotherapy for stage T1-T2N0M0 lanryngeal cancer: retrospective study of 59 patients at CFB and CHU de Caen.
Cuny F; Géry B; Florescu C; Clarisse B; Blanchard D; Rame JP; Babin E; De Raucourt D
Eur Ann Otorhinolaryngol Head Neck Dis; 2013 Nov; 130(5):251-6. PubMed ID: 23759281
[TBL] [Abstract][Full Text] [Related]
16. [Radiotherapy of supraglottic cancers. Report on 84 patients].
Notter G; Sandberg N; Turesson I; Heikel P
HNO; 1984 Nov; 32(11):460-6. PubMed ID: 6511500
[TBL] [Abstract][Full Text] [Related]
17. Base-of-tongue carcinoma: treatment results using concomitant boost radiotherapy.
Mak AC; Morrison WH; Garden AS; Ang KK; Goepfert H; Peters LJ
Int J Radiat Oncol Biol Phys; 1995 Sep; 33(2):289-96. PubMed ID: 7673016
[TBL] [Abstract][Full Text] [Related]
18. The effect of treatment time and treatment interruption on tumour control following radical radiotherapy of laryngeal cancer.
Barton MB; Keane TJ; Gadalla T; Maki E
Radiother Oncol; 1992 Mar; 23(3):137-43. PubMed ID: 1574592
[TBL] [Abstract][Full Text] [Related]
19. Randomized clinical trial on 7-days-a-week postoperative radiotherapy for high-risk squamous cell head and neck cancer.
Suwiński R; Bańkowska-Woźniak M; Majewski W; Idasiak A; Maciejewski A; Ziółkowska E; Windorbska W; Składowski K; Miszczyk L; Maciejewski B
Radiother Oncol; 2008 May; 87(2):155-63. PubMed ID: 18342964
[TBL] [Abstract][Full Text] [Related]
20. Long-term results of radiotherapy for T1a and T1bN0M0 glottic carcinoma.
Nomiya T; Nemoto K; Wada H; Takai Y; Yamada S
Laryngoscope; 2008 Aug; 118(8):1417-21. PubMed ID: 18528306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
